Picture Kentro Design Corporate and Web Design Berlin 600x60px
Document › Details

Medigene AG. (11/9/12). "Press Release: Medigene Reports Progress in Financial Results and Operations for the First Nine Months of 2012". Martinsried.

Organisations Organisation Medigene AG (FSE: MDG1, Prime Standard)
  Group Medigene (Group)
  Organisation 2 Astellas (Group)
Products Product Veregen®
  Product 2 Eligard®
  Index term 2 Astellas–Medigene: leuprolide, 201007–2011 product acquisition €25m transfer of rights to Eligard to Astellas
Persons Person Mathias, Frank (Rentschler 201604– CEO before Medigene + Amgen GmbH + Servier DE + Hoechst)
  Person 2 Llewellyn-Davies, Peter (Apeiron 201807– CEO before CFO+CBO before Accellerate Partners + Medigene + Wilex)

Record changed: 2019-06-09


Picture [LSUS] – The Business Web Portal 600x60px

More documents for Medigene (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]


SilverSky LifeSciences DxPx Conference 2019 Düsseldorf Medica 600x60px

» top